Skip to main content
. 2010 Oct 12;103(10):1536–1541. doi: 10.1038/sj.bjc.6605938

Table 3. Grades I–II and grades III–IV toxicities (N=95).

Toxicitya Grades I–II, n (%) Grades III–IV, n (%)
Haematological toxicity 34 (35.8) 9 (9.5)
Diarrhea 26 (27.3) 8 (8.5)
Mucositis 24 (25.3) 5 (5.3)
Asthenia 18 (19.0) 2 (2.1)
Emesis 10 (10.6) 1 (1.1)
Haemorrhagesb 11 (11.6) 0 (0.0)
Pain 9 (9.7) 1 (1.1)
Nausea 9 (9.5) 0 (0.0)
Hypertensionc 9 (9.5) 0 (0.0)
Constipation 6 (6.4) 0 (0.0)
Proteinuria 3 (3.2) 1 (1.1)
Hepatic toxicity 1 (1.1) 2 (2.1)
Alopecia 3 (3.2) 0 (0.0)
Headache 2 (2.1) 0 (0.0)
Colic 1 (1.1) 1 (1.1)
Hiccups 2 (2.1) 0 (0.0)
Thrombophlebitis 1 (1.1) 0 (0.0)
Wound healing problems 1 (1.1) 0 (0.0)
Allergic reactions 1 (1.1) 0 (0.0)
Dyspnea 1 (1.1) 0 (0.0)
Edema 1 (1.1) 0 (0.0)
Oesophagitis 1 (1.1) 0 (0.0)
Feverc 1 (1.1) 0 (0.0)
Neuropathy 1 (1.1) 0 (0.0)
a

Infection was also reported in one patient, and lung thromboembolism and haemorrhoids in two patients, but the grade was not recorded.

b

Two patients had this adverse event, but the grade was not recorded.

c

One patient had this adverse event, but the grade was not recorded.